tiprankstipranks
Trending News
More News >
Diaceutics Plc (GB:DXRX)
:DXRX
UK Market

Diaceutics (DXRX) Income Statement

Compare
10 Followers

Diaceutics Income Statement

Last quarter (Q2 2025), Diaceutics's total revenue was £14.56M, an increase of 46.76% from the same quarter last year. In Q2, Diaceutics's net income was £-2.40M. See Diaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 32.16M£ 23.70M£ 19.50M£ 13.94M£ 12.70M
Gross Profit
£ 28.27M£ 19.71M£ 14.04M£ 10.57M£ 9.33M
Operating Expenses
£ 30.73M£ 22.72M£ 13.71M£ 10.25M£ 9.94M
Depreciation and Amortization
£ 4.63M£ 4.77M£ 3.01M£ 1.80M£ 809.00K
EBITDA
£ 2.77M£ 2.36M£ 3.61M£ 2.35M£ 178.00K
Operating Income
£ -2.46M£ -3.02M£ 575.00K£ 550.00K£ -610.00K
Other Income/Expenses
£ 547.00K£ 580.00K£ -11.00K£ -88.00K£ -319.00K
Pretax Income
£ -1.91M£ -2.44M£ 564.00K£ 462.00K£ -929.00K
Net Income
£ -1.70M£ -1.75M£ 724.00K£ 561.00K£ 263.00K
Per Share Metrics
Basic EPS
£ -0.02£ -0.02£ 0.01£ 0.01£ 0.00
Diluted EPS
£ -0.02£ -0.02£ 0.01£ 0.01£ 0.00
Weighted Average Shares Outstanding
84.45M 84.23M 84.15M 83.94M 77.53M
Weighted Average Shares Outstanding (Diluted)
84.45M 84.23M 86.09M 84.94M 77.83M
Currency in GBP

Diaceutics Earnings and Revenue History